SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-19-006085
Filing Date
2019-05-07
Accepted
2019-05-07 16:38:37
Documents
6
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 6-K q1-2019x6k.htm 6-K 21877
2 EXHIBIT 99.1 q1-2019xex991fsxquarterly.htm EX-99.1 757650
3 EXHIBIT 99.2 q1-2019xex992mdaxquarterly.htm EX-99.2 220158
4 EXHIBIT 99.3 q1-2019xex993certification.htm EX-99.3 12591
5 EXHIBIT 99.4 q1-2019xex994certification.htm EX-99.4 12554
6 aeternazentarislogoa86.jpg GRAPHIC 14150
  Complete submission text file 0001628280-19-006085.txt   1045612
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 19803676
SIC: 2834 Pharmaceutical Preparations